Memac (Donepezil Hydrochloride)

Donepezil works by reversibly inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine. By blocking this enzyme, the drug raises acetylcholine levels in the brain, enhancing cholinergic neurotransmission that is typically reduced in Alzheimer’s disease, thereby supporting cognition.

The dosage of Memac is individualized. A prescriber determines the appropriate strength and titration schedule based on the patient’s clinical condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescribing information provided by their healthcare provider.

Safety of donepezil in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.

To order Memac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any required import documentation.

Memac (donepezil) belongs to the acetylcholinesterase inhibitor class, similar to rivastigmine and galantamine. Compared with these agents, donepezil is often preferred for its once‑daily dosing and a relatively favorable side‑effect profile, though individual response varies and treatment choice depends on patient‑specific factors.

Memac should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight to maintain stability throughout its shelf life.

Memac is taken orally, usually once daily with or without food, as directed by the prescribing clinician. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include bradycardia, heart block, severe gastrointestinal bleeding, seizures, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for these events, especially if they have pre‑existing cardiac conditions or are taking interacting medications.

Memac is contraindicated in patients with known hypersensitivity to donepezil or any excipients, and should be used with caution in individuals with severe cardiac conduction disorders, active peptic ulcer disease, or uncontrolled asthma. A healthcare professional must evaluate suitability before initiating therapy.